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Abstract
The adherence to the principles of the Universal Protocol for preventing wrong site, wrong
procedure and wrong person surgical or invasive procedures is a requirement for all Joint
Commission accredited organizations. Fine needle aspirations are considered invasive procedures,
and cytopathologists performing this procedure need to be cognizant and compliant with the
requirements of this Joint Commission on Accreditation of Healthcare Organizations (JCAHO)
Protocol. This article gives background perspective on the development of the Universal Protocol.
It also elaborates the JCAHO National Patients Safety Goals regarding the performance of fine
needle aspirations. The compliance with the Universal Protocol for performance of fine needle
aspirations is now mandated for all cytopathologists who perform fine needle aspirations and this
present paper provides a guideline for fulfilling the requirements of the Universal Protocol for
practicing cytopathologists.
Background
The subject of wrong site surgery and factors leading to it,
have been a topic of discussion in medical and legal pub-
lications as well as mainstream press [1]. This issue has
become prominent because of profound patient care,
social and medico legal consequences. A report by the
institute of Medicine estimated that 44,000 to 98,000
individuals in the United States die each year of preventa-
ble medical errors, which have an estimated cost of
approximately 9 billion dollars to United States taxpayers
[2,3]. Fine needle aspirations are considered invasive pro-
cedures which depending on the diagnosis rendered, lead
to definitive surgical procedures. This can profoundly
impact the practice of a fine needle aspiration service in
clinical setting, and hence JCAHO requiring implementa-
tion of the Universal Protocol and "time out" for these
procedures. The "time out" or immediate preprocedural
process is the implementation and expectation of comple-
tion, for JCAHO mandated requirements.
Development of the Universal Protocol
The Joint Commission on Accreditation of Healthcare
Organizations (JCAHO), hosted a Wrong Site Surgery
Summit on May 9, 2003 [4,5]. The goal of this summit
was to obtain a consensus on the adoption of a "Universal
Protocol" for preventing wrong site, wrong procedure and
wrong person surgical or invasive procedures, which
includes fine needle aspirations. The Summit was hosted
by the JCAHO in collaboration with various organizations
including the American Medical Association and Ameri-
can College of Physicians [4,5]. The participants, which
included 30 other professional groups agreed that a Uni-
versal Protocol would help prevent the occurrence of
wrong site, wrong procedure and wrong person surgical or
invasive procedures. They also agreed that the Protocol
Published: 20 September 2007
CytoJournal 2007, 4:19 doi:10.1186/1742-6413-4-19
Received: 21 April 2007
Accepted: 20 September 2007
This article is available from: http://www.cytojournal.com/content/4/1/19
© 2007 Siddiqui; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.CytoJournal 2007, 4:19 http://www.cytojournal.com/content/4/1/19
Page 2 of 4
(page number not for citation purposes)
should be specific and eliminate confusion about site
marking and facilitate communication among patient
care members.
A broad consensus on the draft of the Universal Protocol
was sought, subsequent to which, JCAHO approved the
Universal Protocol for Preventing Wrong Site, Wrong Pro-
cedure and Wrong Person Surgery™ in July 2003 [4,5].
This Universal Protocol was thus created to address the
continuing occurrence of medical errors in JCAHO accred-
ited organizations and became effective July 1, 2004 for
all accredited hospitals, ambulatory care and office-based
surgery facilities [4,5]. The Universal Protocol is applica-
ble to all operative and other invasive procedures, includ-
ing pathologist performed fine needle aspirations. The
principal components of the Universal Protocol include
1) The pre-operative verification process; 2) marking of
the operative site; 3) taking a "time out" immediately
before starting the procedure; and 4) adaptation of the
requirements to non-operating room settings, including
clinic and bedside procedures. These principal compo-
nents of the Universal Protocol are further elaborated in
Tables 1, 2, 3, 4, [4,5].
JCAHO National Patient Safety Goals
The 2007 JCAHO National Patient Safety Goals address
the specific application of the Universal Protocol to inva-
sive procedures performed by the clinical laboratory pro-
fessionals, which includes pathologists performing fine
needle aspirations [6]. The goal that applies to patholo-
gists performing fine needle aspirations is as follows:
Goal 1: Improve the accuracy of patient identification
The rationale for this goal is to prevent the occurrence of
wrong patient identification. Hence, the intent for this
goal is two fold: first to reliably identify the individual as
the person for whom the service or treatment is intended
and secondly, to match the service provided to that
patient. This goal has two main requirements, and the fail-
ure to comply with these requirements may trigger loss of
JCAHO accreditation status, for JCAHO accredited institu-
tions.
Requirement 1A
This requirement states that at least two patient identifiers
(neither to be a room number) be used, whenever collect-
ing laboratory samples, which also include pathologist
performed, fine needle aspirations. To implement this
Table 3: "Time out" immediately before starting the procedure 
(modified from references 4 and 5)
Must be conducted in the location where the procedure will be 
done, just before starting the procedure. It must involve the 
entire operative team, use active communication, be briefly 
documented, such as in a checklist (the organization should 
determine the type and amount of documentation) and must, at 
the least, include:
1. Correct patient identity.
2. Correct side and site.
3. Agreement on the procedure to be done.
4. Correct patient position.
5. Availability of correct implants and any special equipment or 
special requirements.
The organization should have processes and systems in place 
for reconciling differences in staff responses during the "time 
out."
Table 1: Pre-operative verification process (modified from 
references 4 and 5)
Verification of the correct person, procedure, and site 
should occur (as applicable):
1. At the time the surgery/procedure is scheduled.
2. At the time of admission or entry into the facility.
3. Anytime the responsibility for care of the patient is 
transferred to another caregiver.
4. With the patient involved, awake and aware, if possible.
5. Before the patient leaves the preoperative area or enters 
the procedure/surgical room.
A preoperative verification checklist may be helpful to 
ensure availability and review of the following, prior to the 
start of the procedure:
1. Relevant documentation (e.g., History and physical 
examination, consent).
2. Relevant images properly labeled and displayed.
3. Any required implants and special equipment.
Table 2: Marking the operative site (modified from references 4 
and 5)
1. Make the mark at or near the FNA procedure site. Do not 
mark any non-operative site(s) unless necessary for some 
other aspect of care.
2. The mark must be unambiguous (e.g., use initials or "YES" or 
a line representing the proposed incision; consider that "X" 
may be ambiguous)
3. The mark must be positioned to be visible after the patient is 
prepped and draped.
4. The mark must be made using a marker that is sufficiently 
permanent to remain visible after completion of the skin 
prep. Adhesive site markers should not be used as the sole 
means of marking the site.
5. The method of marking and type of mark should be 
consistent throughout the organization and be used by all 
pathologists.
6. At a minimum, mark all cases involving laterality, multiple 
structures (fingers, toes, lesions), or multiple levels (spine).
7. The person performing the procedure should do the site 
marking.
8. Marking must take place with the patient involved, awake and 
aware.
9. Final verification of the site mark must take place during the 
"time out."
10. A defined procedure must be in place for patients who refuse 
site marking.CytoJournal 2007, 4:19 http://www.cytojournal.com/content/4/1/19
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requirement for fine needle aspirations, acceptable identi-
fiers may be the patient's name, an assigned identification
number, telephone number, photograph, or other per-
son-specific identifiers. A bar code on a wrist band that
includes two or more person-specific identifiers will com-
ply with this requirement. This requirement covers the
pre-procedural verification process, and should be per-
formed before the fine needle aspiration procedure is per-
formed.
Requirement 1B
This requirement states that prior to the start of any inva-
sive procedure, conduct a final verification process to con-
firm the correct patient, procedure, site and availability of
appropriate documents. This verification process uses
active, and not passive, communication techniques. The
patient's identity has to be re-established if the patholo-
gist leaves the patient's location, prior to initiating the
procedure. Marking the site is also required unless the
practitioner is in continuous attendance from the time of
the decision to do the procedure and patient consent to
the initiation of the procedure [2]. The mark must be
made using initials or "YES", since "X" is considered
ambiguous. The mark must be made using a marker that
is sufficiently permanent to remain visible after comple-
tion of the skin prep, with alcohol. The implementation
and expectation of completion, for this requirement, is
called "time out".
The "time out" is the immediate preprocedural process,
and must occur in the location where the procedure is to
be done (for example, when the patient is in the fine nee-
dle aspiration clinic). The "time out" should involve the
entire procedural team which, at a minimum, includes the
pathologist doing the procedure, the anesthesia provider
(if any), and the circulating nurse, resident, or other assist-
ant. In addition, there should be no barrier to anyone
speaking up if there is a concern about a possible error.
"Active" communication, in this context, means an affir-
mation, orally or by some action that the patient, proce-
dure and site are correct.
Discussion
An important component of fostering a culture of patient
safety in a health care setting is having all health care pro-
viders adopt common procedures and safeguards to
decrease the risk of harm to patients [7]. This is the goal of
the Universal Protocol that was implemented nationwide
in 2004 to help prevent medical injuries and deaths
caused by wrong-site, wrong-procedure or wrong-identity
of a patient during surgery or other invasive procedures,
including pathologist performed fine needle aspirations
[8,9].
Like most hospitals, the Emory University Hospital has
implemented this Protocol and has put into place a policy
and process for clinicians, including pathologists, to fol-
low. The first step is to verify the patient's identity using at
least two patient identifiers, which can be the patient's
name, birth date or medical record number. Then the
intended procedure also is confirmed by checking the pro-
cedure consent form, the history or progress notes, nurs-
ing assessment and, if applicable, the procedure/surgical
operating room schedule (Table 1) [4,5].
The second step is that the procedure site must be properly
marked to identify the area of the patient's body that will
undergo the procedure before an incision is made (Table
2) [4,5]. For example, if a patient is having a fine needle
aspiration of the left breast, the pathologist would write
"YES" on the patient's left breast area to distinguish the
site from the right breast. The patient is also an integral
part of this safety practice and participates by verifying his
or her identity as well as confirming correct procedure,
correct side and site.
Before the procedure starts, a third step or "time out" is
initiated by the physician conducting the procedure to
give all members of the clinical team an opportunity to
perform a final verification of the correct patient, correct
procedure, correct side, correct site, correct patient posi-
tion and availability of any special equipment or require-
ments that are needed for the fine needle aspiration
procedure (Table 3) [4,5].
JCAHO requires that pathologist performed fine needle
aspiration procedures adhere to the rules of the Universal
Protocol including the implementation of "time out" for
these procedures. The "time out" procedure also needs to
be documented for JCAHO inspectors to review. This can
be done either by documenting "time out" as a note in the
patient's medical file, which is retained as a hard copy in
the patient's medical records. Alternatively, "time out" can
be also be documented by incorporating it as part of the
Table 4: Procedures for non-operating room settings including 
bedside procedures (modified from references 4 and 5)
1. Site marking must be done for any procedure that involves 
laterality, multiple structures or levels (even if the procedure 
takes place outside of a surgical operating room).
2. Verification, site marking, and "time out" procedures should be 
as consistent as possible throughout the organization, including 
the operating rooms and other locations where invasive 
procedures are done.
3. Exception: Cases in which the individual doing the procedure is 
in continuous attendance with the patient from the time of 
decision to do the procedure and consent from the patient 
through to the conduct of the procedure may be exempted 
from the site marking requirement. The requirement for a 
"time out" final verification still applies.Publish with BioMed Central    and   every 
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fine need aspiration report. A text reading out as "The
patient is identified using two identifiers. The site of the
fine needle aspiration procedure is also verified with
the patient. The lesion is palpated, correctly identified,
and marked with ink during time out completion",
incorporated in the Fine needle aspiration report will con-
form completion of "time out" for the procedure.
At our institution, the Universal Protocol has been imple-
mented for all pathologist performed fine needle aspira-
tions. This has been in effect since January 01, 2005. In the
years 2005 and 2006, a total of 1,779 and 2,079 fine nee-
dle aspirations, respectively, were performed by patholo-
gists. In reviewing this data, no errors were detected based
on wrong person or wrong site. In summary, at our insti-
tution, the implementation of the Universal Protocol has
been successful, since conforming to it necessitates that
appropriate time be allocated for its compliance and
hence prevent any error in patient identity or site identifi-
cation, for patients about to undergo a fine needle aspira-
tion.
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